- Resources
- Here
Universal Infectious Disease Assay Facilitated by CRISPR Mediated Depletion - Jumpcode Genomics
Jon Armstrong - Vice President, Research & Development at Jumpcode Genomics
- Comparative performance of NGS platforms in a novel universal infectious disease assay
- AVITI™ highly concordant in identifying all COVID samples tested regardless of Ct value
- AVITI highly concordant in identifying all 49 non-human organisms tested
Contact Sales
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.